Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D).

GLP-1 weight loss and diabetes drugs like Ozempic and Wegovy may impact mental health, as studies show mixed results on mood changes, depression and anxiety.

Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment.

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 RAs may help prevent the disease.

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests by: CARLA K. JOHNSON, Associated Press Posted: May 22, 2025 / 03:42 PM MDT Updated: May 22, 2025 / 03:50 PM MDT ...

Now, a study of 170,000 patient records suggests there’s a slightly lower risk of obesity-related cancers in U.S. adults with diabetes who took these popular medications compared to those who ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood sugar and aid weight loss — could significantly cut dementia risk ...

Study findings Overall, overweight adults who lost enough weight to become healthy, and kept it off, had a lower risk of chronic disease. This was independent of the change in type 2 diabetes risk.